glp 1 orforglipron Mechanism of Action: How It Works Orforglipron: The First Approved Oral,

1,2 This review evaluates the proposed mechanisms of action of GLP-1RAs, critically analyses recent evidence from clinical trials and considers the optimal clinical use of GLP-1RAs and potential future directions

GLP-1 receptor agonists were initially developed for glycemic control, but outcome trials have fundamentally changed how these therapies are viewed

Your prescriber will use whichever pathway matches your primary diagnosis

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

This is evident from studies where exenatide blunted the fMRI signal in brain areas such as the amygdala, insula, hippocampus, and frontal cortex in obese individuals but not in lean individuals [16, 17]